Stephen Rushworth Smith, Director at Allergy Therapeutics, holds 776.51K shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Stephen Rushworth Smith Bought 20,000p shares of Allergy Therapeutics on Apr 20, 2012 for an estimated value of ―.